Troels Lillebæk

Research area

Director and responsible for the research strategy at the International Reference Laboratory of mycobacteriology (IRLM) at Statens Serum Institut (SSI) focusing on tuberculosis and non-tuberculous mycobacteria research based on microbiological, molecular, immunological, and pharmacological methods. Especially interested in molecular epidemiology and interpretation of genotyping data. Supervision (previous/ongoing) of nine PhD´s, one MPH and two ”postdoc”. 

PubMed link

https://www.ncbi.nlm.nih.gov/pubmed/?term=lillebaek+t+NOT+seestoft

Responsibilities

Director at IRLM which performs laboratory based diagnostics, surveillance and research on tuberculosis and non-tuberculous mycobacteria for Denmark, Greenland, Iceland, and the Faroe Islands.

Serves as national- and international expert, e.g. in connection with WHO (Supranational Reference Laboratory Network), ECDC (TB Disease Network Coordinating Committee & European Reference Laboratory TB Network), European Society of Mycobacteriology (Steering Committee & Vice President), and the Danish "National Tuberculosis Group".

Clinical work as Consultant ID-specialist in the Infectious Diseases Outpatient Clinic at Zealand University Hospital Roskilde.

Publikationer

Full PubMed list at: https://www.ncbi.nlm.nih.gov/pubmed/?term=lillebaek+t+NOT+seestoft